Financial assessment
As part of the evaluation of the EANM’s eligibility for involvement in the activities of EMA, the following financial information is provided for EMA’s assessment (data pertaining to the financial year 2022):
Non-industry income: 3.253.823,92 €
Split of non-industry income (in % of total income)
- Registration fees: 41.93%
- Membership fees: 5,31%
- Educational events: 1,99%
- EU project funding: 0.36%
- Donations: 0.17%
- Other income: 4,94%
Industry income: 2.691.205,00 €
Split of industry income (in % of total income)
- Congress and events: 42.07%
- Corporate membership: 3,20%
The highest contribution from a single company is 2,76% of the overall income.
The overall proportion of industry vs non-industry income in 2022 was 54.73% vs 45,27%.
Industry partners 2022
The following companies provided financial contributions to the EANM.
A.C.O.M Advanced Center
ABX GmbH
ABX-CRO advanced pharmaceutical services
Advanced Accelerator Applications Inter.
Advanced Cyclotron Systems Invc
Alliance Medical GmbH
APR 1998 S. L.
Artbio Inc
AtomVie Global Radiopharma Inc
Augmenticon AG
AWEX – Agence Wallone a l’Exortation
Bayer Aktiengesellschaft
Best Cyclotron Systems Inc.
Blue Earth Diagnostics Ltd.
Boston Scientific International SA
Brightonix Imaging Inc.
Bruker BioSpin GmbH
BV RPO NucleoGenesis
Capintec, Inc.
Casram SA
CheMatech
CIS Bio International
Clarity Pharmaceuticals
Clerad
CMR
Comecer SpA
Crystal Photonics GmbH
CUP Laboratorien Dr. Freitag GmbH
Curium PET France SA
Cyclomedica Europe Ltd.
diXit s.r.l.
Dosisoft
ec2 Software Solutions
Eckert & Ziegler Eurotope GmbH
Eczacibasi-Monrol Nuclear Products Co.
Eli Lilly and Company USA
ERAS Labo SAS
European Isotopes Transport Association
Evergreen Theragnostics
Gamma Medical Technology
GE Healthcare LTD
GE Medical Systems Societe en Commandite
General Equipment for Medical Imaging S.
Getinge La Calhene
HERMES Medical Solutions AB
IBA S.A.
ICPO Foundation
Imagin AB
Incepto Medical SAS
InnoGamma Ltd.
Institute of Isotopes Co Ltd.
Inter Medical Medizintechnik GmbH
International Isotopes
INVIA Medical Imaging Solutions
inviCRO SAS
Inviscan SAS
Ionetix
Iotron Medical Inc.
iPHASE technologies
Isotopia Molecular Imaging Ltd.
Itel Telecomunicazioni
ITM Oncologics
Jagiellonian University
Jiangsu Huayi Technology Co. Ltd.
Jubilant Draximage
LabLogic Systems Ltd.
Laboratoires Cyclopharma
Lemer Pax
Life Molecular Imaging GmbH
Lilly France
Medi-Radiopharma Ltd.
Mediso Ltd.
Medizinische Universität Wien
MedTrace AS
MiE medical imaging electronics GmbH
MILabs BV
MIM Software Inc.
Mirion Technologies
MNT Saglik Hizmetleri A. S.
Molecubes NV
MR Solutions Ltd.
NRG – Mrs. Rosali Meyer
Nuclear Medicine Europe (NMEU)
Nuclear Shields BV
NV XEOS MEDICAL
Oak Ridge National Labratory-UT Battelle
OncoBeta GmbH
Oncodesign
Optimized Radiochemical Applications
P.B.L. SRL
Pars Isotope Co. (Iran)
PentixaPharm GmbH
Pepscan Presto B.V.
Pfizer
Philochem AG
PI Medical Diagnostic Equipment B.V.
Piur Imaging GmbH
PMB-Alcen
Polatom
Polskie Towarzystwo Medycyhy
Positrigo AG
Precirix NV
Qubiotech Health Intelligence, S.L.
Radiaprot s.l
Radioprotech
Radon Saglik Hizmetleri Üretim
Rescue Dose Ltd.
RI-TE Radiation Imaging Technologies Lda
Rotem GmbH
ROTOP Pharmaka GmbH
RPO Radiomolecular Precision Oncology
Scintomics GmbH
SERFA, Sociedad Espanola de Radiofrmacia
SHINE Medical Technologies, LLC
Siemens Healthcare GmbH
Sirtex Medical Europe GmbH
Spectrum Dynamics Medical SA
Springer Nature Switzerland AG
Stockholms Universitet
Sumitomo Heavy Industries, Ltd.
Sylvia Fedoruk Canadian Centre for
Synthra GmbH
Taiyo Nippon Sanso Corp.
Telix Pharmaceuticals Limited
TEMA Sinergie S.p.A.
Terumo Europe NV
The Oncidium Foundation
Theragnostics LTD
Trasis SA
TRF Tecnicas Radiofisicas S.L
Triskem International
United Imaging Healthcare
UT Battelle, LLC for de Dept. of Energy
Vent-Medis GmbH
Von Gahlen Nederland BV
Wälischmiller Engineering GmbH
Waters Corporation
Wiener Tourismusverband